Loading...
132 Middle East and Africa Chronic Disorder Drugs Reports
Country Covered: South Africa
Study Period: 2018 - 2029
Major Players: AstraZeneca, Merck, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Country Covered: Saudi Arabia
Study Period: 2018 - 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Merck and Co., Novo Nordisk A/S, Sanofi Aventis
Region Covered: Middle East and Africa
Study Period: 2018 - 2029
Countries Covered: Saudi Arabia, Iran, Egypt, Oman, South Africa
Major Players: Boehringer Ingelheim, Astrazeneca, Eli Lilly, Sanofi, Novo Nordisk
Country Covered: Egypt
Study Period: 2019 - 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis, Eli Lilly and Company
Region Covered: Middle East and Africa
Study Period: 2018 - 2029
Countries Covered: Egypt, Iran, Oman, Saudi Arabia, South Africa
Major Players: Bristol Myers Squibb, Teva, Sanofi Aventis, Merck and Co., Glenmark Pharmaceuticals
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Philips, Colgate, DMG Dental, VOCO GmbH, Dentsply Sirona
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Alcon Inc., Bausch Health Companies Inc., Johnson & Johnson, Carl Zeiss Meditec AG, Topcon Corporation
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Dermamed Solutions, AbbVie Inc (Allergan, Inc), Obagi Cosmeceuticals LLC, Merz GmbH & Co. KGaA, L'Oréal SA
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Medtronic PLC, Astellas Pharma, Inc., Macleods Pharmaceuticals Ltd, Pfizer, Inc, AbbVie Ltd.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc. (Allergan, Inc.), Merck & Co., Inc.,, Novartis AG, Bausch Health Companies Inc. , Johnson & Johnson
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Takeda Pharmaceutical Company Limited , Bristol-Myers Squibb, LUPIN, Accord Healthcare, Otsuka America Pharmaceutical, Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Eli Lilly and Company, Pfizer Inc., Johnson and Johnson (Janssen Global Services, LLC), Novartis AG, Amgen Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Merck & Co. Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Azurity Pharmaceuticals, Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Novartis AG , Bristol-Myers Squibb, Incyte Corporation, Takeda Pharmaceutical Company Limited, Viatris (Mylan N.V.)
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbvie Inc. , AstraZeneca, Takeda Pharmaceutical Company Limited, Bausch Health Companies Inc. (Salix Pharmaceuticals Inc.), Johnson & Johnson(Janssen Global Services LLC)
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Evoke Pharma, AstraZeneca, Cadila Pharmaceuticals, Neurogastrx, Inc., AbbVie Inc. ( Allergan Plc)
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories Inc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Endo International, Ferring Pharmaceuticals
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc., AstraZeneca PLC, Hoffmann-La Roche AG, Eli Lilly and Company , GSK plc
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Gilead Sciences, Novartis AG, Sanofi, Astellas Pharma Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, Axogen Corporation, Medtronic, Boston Scientific Corporation, Integra LifeSciences Corporation
Region Covered: Middle East and Africa
Study Period: 2018 - 2028
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories, GlaxoSmithKline PLC, Johnson & Johnson Health Care Systems Inc., Novartis AG, UCB S.A.
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bausch Health Companies Inc., F. Hoffmann-La Roche AG, Mylan N.V., Sun Pharmaceuticals Ltd., Merck & Co. Inc.
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Africa, Brazil, Argentina
Major Players: Pfizer Inc., Abbvie Inc., Bristol Myers Squibb, Regeneron Pharmaceuticals, Inc., Evelo Biosciences, Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbvie Inc., Merck KGaA, Pfizer Inc., Exelixis Inc., Viatris Inc.
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc., Bausch Health Companies Inc., Novartis AG, AbbVie Inc., Almirall SA
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc (Allergan Plc), Ipsen SA, Medytox Inc., Merz Pharma, Sinclair Pharma Plc
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc, AstraZeneca Plc, Novartis AG, Novo Nordisk A/S, Eli Lilly and Company
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc., Eli Lilly (Dermira), Advin Health Care, Dermavant (Roivant Sciences), Brickell Biotech Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bioness Inc. , Saebo Inc. , Boston Orthotics & Prosthetics , Ottobock, Ossur
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Aclaris Therapeutics, Bausch Health Companies, Sol-Gel Technologies Ltd., Journey Medical Corporation (Fortress Biotech, Inc.), Galderma
Filter Reports
By Countries
